A multi-center retrospective study of neuroendocrine tumors of the uterine cervix: Prognosis according to the new 2018 staging system, comparing outcomes for different chemotherapeutic regimens and histopathological subtypes.

•A multicenter, retrospective study of neuroendocrine tumors of the uterine cervix was undertaken.•Locally-advanced and extra-pelvic disease were independent prognostic factors for NET of the cervix.•HGNEC showed good responses to EP or CPT-P regimens but not to TC.•ACT was less responsive to chemotherapy and had a prognosis identical to HGNEC.